KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume $8.36 +0.27 (+3.34%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KalVista Pharmaceuticals Short Interest DataKalVista Pharmaceuticals (KALV) has a short interest of 7.26 million shares. This marks a -1.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 17.6, indicating that it would take 17.6 days of the average trading volume of 478,905 shares to cover all short positions.Current Short Interest7,260,000 sharesPrevious Short Interest7,370,000 sharesChange Vs. Previous Month-1.49%Dollar Volume Sold Short$73.04 millionShort Interest Ratio17.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares49,418,000 sharesPercentage of Shares Shorted14.69%Today's Trading Volume1,014,235 sharesAverage Trading Volume478,905 sharesToday's Volume Vs. Average212% Short Selling KalVista Pharmaceuticals? Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKALV Short Interest Over TimeKALV Days to Cover Over TimeKALV Percentage of Float Shorted Over Time Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. KalVista Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20247,260,000 shares $73.04 million -1.5%N/A17.6 $10.06 11/15/20247,370,000 shares $69.94 million +7.3%N/A17.7 $9.49 10/31/20246,870,000 shares $70.55 million +0.9%N/A19 $10.27 10/15/20246,810,000 shares $81.58 million +4.6%N/A20.1 $11.98 9/30/20246,510,000 shares $75.39 million +13.8%N/A17 $11.58 9/15/20245,720,000 shares $63.72 million +1.2%N/A15.6 $11.14 Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20245,650,000 shares $75.65 million -0.5%N/A17.4 $13.39 8/15/20245,680,000 shares $72.65 million -5.0%N/A17.9 $12.79 7/31/20245,980,000 shares $86.95 million -5.5%N/A18.3 $14.54 7/15/20246,330,000 shares $94.70 million +7.7%N/A18.4 $14.96 6/30/20245,880,000 shares $69.27 million +4.3%N/A17.7 $11.78 6/15/20245,640,000 shares $68.07 million +2.2%N/A15.4 $12.07 5/31/20245,520,000 shares $64.42 million -4.2%N/A14.1 $11.67 5/15/20245,760,000 shares $69.18 million +4.0%N/A11.7 $12.01 4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35 4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74 3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86 3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93 2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65 2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76 1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77 1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96 12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25 12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68 11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44 11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69 10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49 10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08 9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63 9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82 8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85 8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81 7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10 7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64 6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00 6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63 5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75 5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11 4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53 4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86 3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45 2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33 2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73 1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96 1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10 12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76 12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72 11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39 11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22 10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07 10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56 9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51 9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81 8/31/20222,350,000 shares $38.70 million +14.6%11.2%10.7 $16.47 8/15/20222,050,000 shares $32.41 million +8.5%9.8%7.3 $15.81 7/31/20221,890,000 shares $23.34 million +2.7%9.0%6.1 $12.35 7/15/20221,840,000 shares $22.69 million +3.4%8.7%5.7 $12.33 6/30/20221,780,000 shares $17.52 million -16.8%8.5%5.3 $9.84 6/15/20222,140,000 shares $19.07 million +58.5%10.2%6.4 $8.91 5/31/20221,350,000 shares $12.00 million +7.1%6.4%4.6 $8.89 5/15/20221,260,000 shares $12.23 million +37.7%6.0%5.4 $9.71 4/30/2022914,800 shares $11.65 million +4.6%4.3%4.4 $12.73 4/15/2022874,800 shares $12.56 million -19.7%4.2%4.2 $14.36 3/31/20221,090,000 shares $16.07 million -17.4%5.2%5.2 $14.74 3/15/20221,320,000 shares $19.14 million +1.5%6.3%6.6 $14.50 2/28/20221,300,000 shares $20.87 million +13.0%6.2%6.3 $16.05 2/15/20221,150,000 shares $18.95 million -5.7%5.5%5 $16.48 1/31/20221,220,000 shares $15.40 million +15.1%5.8%5.7 $12.62 1/15/20221,060,000 shares $13.29 million +11.9%5.0%5 $12.54 12/31/2021947,400 shares $12.53 million +0.4%4.5%4.7 $13.23 12/15/2021943,800 shares $12.81 million -2.2%4.2%4.4 $13.57 11/30/2021964,800 shares $13.99 million -6.3%4.3%4.4 $14.50 11/15/20211,030,000 shares $17.94 million -5.5%4.6%5.4 $17.42 10/29/20211,090,000 shares $19.60 million -11.4%4.9%5.8 $17.98 10/15/20211,230,000 shares $21.17 million +3.4%5.5%6.9 $17.21 9/30/20211,190,000 shares $20.77 million -14.4%5.4%6.5 $17.45 9/15/20211,390,000 shares $26.76 million -21.0%6.2%7 $19.25 8/31/20211,760,000 shares $35.97 million -4.9%7.9%8.7 $20.44 8/13/20211,850,000 shares $35.72 million -4.2%8.3%8.6 $19.31 7/30/20211,930,000 shares $38.87 million -1.5%9.5%8.5 $20.14 7/15/20211,960,000 shares $43.04 million -2.0%9.9%7.7 $21.96 6/30/20212,000,000 shares $47.92 million +39.9%10.1%6.7 $23.96 6/15/20211,430,000 shares $40.78 million +3.6%7.2%4.6 $28.52 5/28/20211,380,000 shares $37.26 million -3.5%7.0%4.2 $27.00 5/14/20211,430,000 shares $35.91 million +6.7%N/A3.9 $25.11 4/30/20211,340,000 shares $33.81 million +3.1%N/A1.2 $25.23 4/15/20211,300,000 shares $32.40 million +10.2%N/A1.2 $24.92 3/31/20211,180,000 shares $30.33 million +51.8%N/A1.2 $25.70 3/15/2021777,400 shares $25.27 million -0.6%N/A0.8 $32.50We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 2/26/2021782,400 shares $25.99 million +22.0%N/A0.9 $33.22 2/12/2021641,100 shares $25.93 million +25.0%3.8%0.7 $40.45 1/29/2021513,100 shares $8.02 million +28.2%4.5%0.8 $15.64 1/15/2021400,200 shares $6.88 million +4.7%3.5%3.3 $17.18 12/31/2020382,400 shares $7.22 million +27.3%3.4%3.2 $18.89 12/15/2020300,300 shares $5.69 million -11.6%2.7%3 $18.95 11/30/2020339,700 shares $6.61 million +3.9%3.0%3.8 $19.47 11/15/2020326,900 shares $6.15 million +47.0%2.8%3.8 $18.80 10/30/2020222,400 shares $3.83 million -12.3%1.9%2.9 $17.22 10/15/2020253,600 shares $3.79 million +2.3%2.2%3.7 $14.95 9/30/2020247,900 shares $3.12 million -16.4%2.1%3.8 $12.59 9/15/2020296,600 shares $4.12 million -7.1%2.5%3.4 $13.88 8/31/2020319,100 shares $4.18 million -10.6%2.7%2.6 $13.10 8/14/2020356,900 shares $4.53 million -9.2%2.8%2.8 $12.70 7/31/2020392,900 shares $3.86 million -8.7%3.1%2.9 $9.83 7/15/2020430,200 shares $4.97 million +9.8%3.4%3.2 $11.56 6/30/2020391,800 shares $4.74 million +24.2%3.1%2.8 $12.10 6/15/2020315,500 shares $3.28 million -7.5%2.5%2.3 $10.40 5/29/2020341,200 shares $3.71 million +1.2%2.7%2.6 $10.86 5/15/2020337,200 shares $3.42 million -2.7%2.7%2.3 $10.15 4/30/2020346,600 shares $4.10 million -3.5%2.8%2.5 $11.82 4/15/2020359,200 shares $3.70 million -10.6%2.9%2.6 $10.30 3/31/2020401,600 shares $4.47 million -33.9%3.2%2.8 $11.14 3/13/2020607,100 shares $5.77 million -2.5%4.8%3.1 $9.51 2/28/2020622,600 shares $4.40 million +0.8%4.9%4.6 $7.06 2/14/2020617,500 shares $6.42 million -11.9%4.9%4.6 $10.40 1/31/2020700,600 shares $9.64 million -3.5%5.6%5.2 $13.76 1/15/2020725,700 shares $11.05 million -17.3%5.8%5.3 $15.23 12/31/2019877,600 shares $14.99 million +11.3%7.0%6.2 $17.08 KALV Short Interest - Frequently Asked Questions What is KalVista Pharmaceuticals' current short interest? Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 7,260,000 shares of KALV short. Learn More on KalVista Pharmaceuticals' current short interest. What is a good short interest ratio for KalVista Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 18.0. Learn More on KalVista Pharmaceuticals's short interest ratio. Is KalVista Pharmaceuticals' short interest increasing or decreasing? KalVista Pharmaceuticals saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 7,260,000 shares, a decrease of 1.5% from the previous total of 7,370,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does KalVista Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to KalVista Pharmaceuticals: Xencor, Inc. (6.37%), Evotec SE (0.14%), Arcutis Biotherapeutics, Inc. (20.10%), Nurix Therapeutics, Inc. (13.20%), Arcus Biosciences, Inc. (16.69%), Kiniksa Pharmaceuticals, Ltd. (5.57%), Immunocore Holdings plc (14.78%), Ocular Therapeutix, Inc. (6.78%), Mesoblast Limited (1.24%), Intellia Therapeutics, Inc. (18.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short KalVista Pharmaceuticals stock? Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading up $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KalVista Pharmaceuticals? A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further. How often is KalVista Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies XNCR Short Squeeze EVO Short Squeeze ARQT Short Squeeze NRIX Short Squeeze RCUS Short Squeeze KNSA Short Squeeze IMCR Short Squeeze OCUL Short Squeeze MESO Short Squeeze NTLA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KALV Stock Alerts